Clinical Trial

Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-12-31 -> 2027-12-31 2026-08-13
minor Completion pushed: 2025-12-31 -> 2027-12-31 2026-08-13
Trial Details
NCT Number NCT05092295
Lead Sponsor Rebiscan, Inc.
Collaborators: Carilion Clinic
Conditions Brain Injuries, Traumatic
Enrollment 200 participants
Start Date 2021-12-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12